Saturday, August 13, 2022
Home AstraZeneca Vaccine, benefits and risks in younger people AstraZeneca Vaccine, benefits and risks in younger people

AstraZeneca Vaccine, benefits and risks in younger people

AstraZeneca, Vaccine, benefits, risks, younger, thrombosis, thrombocytopenia, Oxford, Covid-19, Eurosurveillance, Vaxzevria, European Medical Agency, EMA

The risk of dying from thrombosis and thrombocytopenia in the under 55 age group using the Oxford – AstraZeneca vaccine is HIGHER than the risk of dying from Covid-19 according to a European Government approved analysis.